Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Using viral load and epidemic dynamics to optimize pooled testing in resource constrained settings

Brian Cleary, View ORCID ProfileJames A. Hay, Brendan Blumenstiel, Maegan Harden, Michelle Cipicchio, Jon Bezney, Brooke Simonton, David Hong, Madikay Senghore, Abdul K. Sesay, Stacey Gabriel, Aviv Regev, Michael J. Mina
doi: https://doi.org/10.1101/2020.05.01.20086801
Brian Cleary
1Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bcleary@broadinstitute.org jhay@hsph.harvard.edu aregev@broadinstitute.org mmina@hsph.harvard.edu
James A. Hay
2Centre for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
3Department of Immunology and Infectious Diseases, Harvard School of Public Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for James A. Hay
  • For correspondence: bcleary@broadinstitute.org jhay@hsph.harvard.edu aregev@broadinstitute.org mmina@hsph.harvard.edu
Brendan Blumenstiel
1Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Maegan Harden
1Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michelle Cipicchio
1Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jon Bezney
1Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Brooke Simonton
1Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Hong
4Wharton Statistics, University of Pennsylvania, Philadelphia, PA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Madikay Senghore
2Centre for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Abdul K. Sesay
5Medical Research Council Unit The Gambia at London School of Hygiene and Tropical Medicine, PO Box 273, Banjul, The Gambia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stacey Gabriel
1Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aviv Regev
6Klarman Cell Observatory, Broad Institute of MIT and Harvard
7Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02142 USA
8Howard Hughes Medical Institute, Chevy Chase, MD, USA
9Genentech, 1 DNA Way, South San Francisco, CA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael J. Mina
1Broad Institute of MIT and Harvard, Cambridge, MA 02142 USA
2Centre for Communicable Disease Dynamics, Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
3Department of Immunology and Infectious Diseases, Harvard School of Public Health
10Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: bcleary@broadinstitute.org jhay@hsph.harvard.edu aregev@broadinstitute.org mmina@hsph.harvard.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Extensive virological testing is central to SARS-CoV-2 containment, but many settings face severe limitations on testing. Group testing offers a way to increase throughput by testing pools of combined samples; however, most proposed designs have not yet addressed key concerns over sensitivity loss and implementation feasibility. Here, we combine a mathematical model of epidemic spread and empirically derived viral kinetics for SARS-CoV-2 infections to identify pooling designs that are robust to changes in prevalence, and to ratify losses in sensitivity against the time course of individual infections. Using this framework, we show that prevalence can be accurately estimated across four orders of magnitude using only a few dozen pooled tests without the need for individual identification. We then exhaustively evaluate the ability of different pooling designs to maximize the number of detected infections under various resource constraints, finding that simple pooling designs can identify up to 20 times as many positives compared to individual testing with a given budget. We illustrate how pooling affects sensitivity and overall detection capacity during an epidemic and on each day post infection, finding that sensitivity loss is mainly attributed to individuals sampled at the end of infection when detection for public health containment has minimal benefit. Crucially, we confirm that our theoretical results can be accurately translated into practice using pooled human nasopharyngeal specimens. Our results show that accounting for variation in sampled viral loads provides a nuanced picture of how pooling affects sensitivity to detect epidemiologically relevant infections. Using simple, practical group testing designs can vastly increase surveillance capabilities in resource-limited settings.

Competing Interest Statement

A.R. is a co-founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas, and until July 31, 2020, was an SAB member of ThermoFisher Scientific, Syros Pharmaceuticals, Asimov, and Neogene Therapeutics. From August 1, 2020, A.R. is an employee of Genentech.

Funding Statement

Work was supported by the Merkin Institute Fellowship at the Broad Institute of MIT and Harvard (B.C.), by the National Institute of General Medical Sciences (#U54GM088558; J.H. and M.M.); and by an NIH DP5 grant (M.M.), and the Dean's Fund for Postdoctoral Research of the Wharton School and NSF BIGDATA grant IIS 1837992 (D.H.).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

An exempt protocol was approved by the Broad Institute ORSP

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

Raw data generated in this study are available in Table S2 and Table S6. Simulated data can be regenerated using the accompanying code.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Back to top
PreviousNext
Posted January 15, 2021.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Using viral load and epidemic dynamics to optimize pooled testing in resource constrained settings
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Using viral load and epidemic dynamics to optimize pooled testing in resource constrained settings
Brian Cleary, James A. Hay, Brendan Blumenstiel, Maegan Harden, Michelle Cipicchio, Jon Bezney, Brooke Simonton, David Hong, Madikay Senghore, Abdul K. Sesay, Stacey Gabriel, Aviv Regev, Michael J. Mina
medRxiv 2020.05.01.20086801; doi: https://doi.org/10.1101/2020.05.01.20086801
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Using viral load and epidemic dynamics to optimize pooled testing in resource constrained settings
Brian Cleary, James A. Hay, Brendan Blumenstiel, Maegan Harden, Michelle Cipicchio, Jon Bezney, Brooke Simonton, David Hong, Madikay Senghore, Abdul K. Sesay, Stacey Gabriel, Aviv Regev, Michael J. Mina
medRxiv 2020.05.01.20086801; doi: https://doi.org/10.1101/2020.05.01.20086801

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (166)
  • Anesthesia (49)
  • Cardiovascular Medicine (447)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
  • Epidemiology (5196)
  • Forensic Medicine (3)
  • Gastroenterology (192)
  • Genetic and Genomic Medicine (746)
  • Geriatric Medicine (76)
  • Health Economics (210)
  • Health Informatics (689)
  • Health Policy (350)
  • Health Systems and Quality Improvement (221)
  • Hematology (98)
  • HIV/AIDS (161)
  • Infectious Diseases (except HIV/AIDS) (5788)
  • Intensive Care and Critical Care Medicine (353)
  • Medical Education (101)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (754)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (140)
  • Occupational and Environmental Health (230)
  • Oncology (473)
  • Ophthalmology (149)
  • Orthopedics (37)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (138)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (135)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (851)
  • Public and Global Health (1983)
  • Radiology and Imaging (340)
  • Rehabilitation Medicine and Physical Therapy (154)
  • Respiratory Medicine (282)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (74)
  • Surgery (107)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)